Copyright indiatimes
Health and Human Services Secretary Robert F. Kennedy Jr., alongside Dr. Mehmet Oz and the U.S. Food and Drug Administration, has unveiled a groundbreaking plan to lower drug prices and accelerate the approval of biosimilars, generic versions of complex biological drugs. The move is expected to save American taxpayers billions and expand access to life-saving treatments for millions.
